Platelet Disorders
PAGE 6 of 10
‹View Table of Contents
Table 5. HTC Population Profile Patient Characteristics, Platelet Disorders, Data Reported from 1/1/2012 through 3/31/2023
| Bernard Soulier syndrome | Glanzmann thrombasthenia | Gray platelet syndrome | Hermansky-Pudlak syndrome | Platelet function disorder, hereditary (nonspecific) | Platelet release defect | Platelet storage pool disease | Thrombocytopenia, hereditary | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # | (%) | # | (%) | # | (%) | # | (%) | # | (%) | # | (%) | # | (%) | # | (%) | ||
| # of patients | 102 | (100) | 347 | (100) | 19 | (100) | 142 | (100) | 4364 | (100) | 56 | (100) | 3814 | (100) | 1089 | (100) | |
| Age (years) | <2 | * | * | * | * | * | * | 6 | (4) | 53 | (1) | * | * | 46 | (1) | 44 | (4) |
| 2–10 | 25 | (25) | 63 | (18) | * | * | 42 | (30) | 765 | (18) | * | * | 734 | (19) | 145 | (13) | |
| 11–19 | 26 | (25) | 101 | (29) | 8 | (42) | 38 | (27) | 1533 | (35) | 31 | (55) | 1597 | (42) | 247 | (23) | |
| 20–44 | 34 | (33) | 115 | (33) | * | * | 39 | (27) | 1213 | (28) | 8 | (14) | 1003 | (26) | 280 | (26) | |
| 45–64 | 10 | (10) | 47 | (14) | * | * | * | * | 478 | (11) | * | * | 304 | (8) | 209 | (19) | |
| 65+ | * | * | 19 | (5) | * | * | * | * | 322 | (7) | * | * | 130 | (3) | 164 | (15) | |
| Sex† | Male | 52 | (51) | 165 | (48) | 8 | (42) | 66 | (46) | 1584 | (36) | 24 | (43) | 1250 | (33) | 518 | (48) |
| Female | 50 | (49) | 182 | (52) | 11 | (58) | 76 | (54) | 2780 | (64) | 32 | (57) | 2564 | (67) | 571 | (52) | |
| Ethnicity | Hispanic, Latino/a, or Spanish origin | * | * | 87 | (25) | * | * | 83 | (58) | 694 | (16) | * | * | 302 | (8) | 256 | (24) |
| Not Hispanic, Latino/a, or Spanish origin | 81 | (79) | 250 | (72) | 13 | (68) | 51 | (36) | 3539 | (81) | 38 | (68) | 3463 | (91) | 770 | (71) | |
| Unknown | * | * | 10 | (3) | * | * | 8 | (6) | 131 | (3) | * | * | 49 | (1) | 63 | (6) | |
| Race | American Indian/Alaska Native | * | * | * | * | * | * | * | * | 24 | (1) | * | * | * | * | 12 | (1) |
| Asian | * | * | 36 | (10) | * | * | 8 | (6) | 163 | (4) | * | * | * | * | 31 | (3) | |
| Black or African American | 9 | (9) | 55 | (16) | * | * | * | * | 431 | (10) | * | * | 442 | (12) | 137 | (13) | |
| Native Hawaiian or other Pacific Islander | * | * | * | * | * | * | * | * | 13 | (0) | * | * | * | * | * | * | |
| White | 81 | (79) | 230 | (66) | 10 | (53) | 93 | (65) | 3437 | (79) | 48 | (86) | 3140 | (82) | 766 | (70) | |
| More than one of these | * | * | * | * | * | * | * | * | 55 | (1) | * | * | 97 | (3) | * | * | |
| Unknown | * | * | * | * | * | * | 31 | (22) | 241 | (6) | * | * | 81 | (2) | 129 | (12) | |
| Insurance Status | Insured | 99 | (97) | 328 | (95) | 19 | (100) | 140 | (99) | 4291 | (98) | 53 | (95) | 3763 | (99) | 1056 | (97) |
| Uninsured | * | * | 9 | (3) | * | * | * | * | 32 | (1) | * | * | 29 | (1) | 27 | (2) | |
| Unknown | * | * | 10 | (3) | * | * | * | * | 41 | (1) | * | * | 22 | (1) | 6 | (1) | |
| History of HCV infection | Yes | * | * | 17 | (5) | * | * | * | (1) | 20 | (0) | * | * | 36 | (1) | 21 | (2) |
| No | 84 | (82) | 281 | (81) | 15 | (79) | 121 | (85) | 3252 | (75) | 32 | (57) | 2806 | (74) | 742 | (68) | |
| Unknown | * | * | 49 | (14) | * | * | * | * | 1092 | (25) | * | * | 972 | (25) | 326 | (30) | |
| History of HIV infection | Yes | * | * | * | * | * | * | * | * | 7 | (0) | * | * | 16 | (0) | 11 | (1) |
| No | 88 | (86) | 298 | (86) | 15 | (79) | 119 | (84) | 3266 | (75) | 32 | (57) | 2820 | (74) | 751 | (69) | |
| Unknown | * | * | * | * | * | * | * | * | 1091 | (25) | * | * | 978 | (26) | 327 | (30) | |
† The HTC Population Profile contains 41 transgender individuals. For confidentiality purposes, the number of transgender patients is too small to report by year or other characteristics. Transgender patients have been included in the counts of male and female according to the sex assigned to them at birth since hemophilia and von Willebrand disease, the most common congenital bleeding disorders, affect the sexes differently.
* Counts greater than zero but less than five have been suppressed to protect patient confidentiality. Additional cells may be suppressed to prevent derivation of these counts by subtraction.
Pages in this Report
- HTC Population Profile
- HTC Population Profile Patient Characteristics
- Factor VIII and Factor IX
- von Willebrand Disease (VWD)
- Rare Factor Deficiencies
- ›Platelet Disorders
- Other Disorders
- Geographic Distribution of Males with Hemophilia A or B
- Geographic Distribution of Females with Hemophilia A or B
- Geographic Distribution of Persons with von Willebrand Disease